| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Research Laboratories, Chugai Pharmaceutical Co., Ltd. (J.A., Y.N.) Takada, Toshima-ku, Tokyo 171
The Department of Dermatology, School of Medicine, Tokyo Medical and Dental University (S.K.) Yushima, Bunkyo-ku, Tokyo 113
The Department of Cancer Cell Research, Institute of Medical Science, University of Tokyo (T.K.) Shirokanedai, Minato-ku, Tokyo 108, Japan
Address all correspondence and requests for reprints to: Toshio Kuroki, M.D., Department of Cancer Cell Research, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo 108, Japan.
1,25-Dihydroxyvitamin D3 [1,25-(OH)2D3], a hormonally active form of vitamin D3, has been reported to stimulate epidermal differentiation and to be an effective treatment of psoriatic lesions. We studied the responsiveness of psoriatic epidermal keratinocytes to 1,25-(OH)2D3 in explantoutgrowth cultures of involved and uninvolved skin from six patients with psoriasis. A feeder layer was required for outgrowth of psoriatic epidermal keratinocytes of involved skin, but not for that of cells of uninvolved skin. The growth of normal epidermal keratinocytes was inhibited by 1,25-(OH)2D3, and the number of DNA-synthesizing cells, determined in autoradiographs, was reduced to about 15% of that in control cultures by 1 nmol/L 1,25-(OH)2D3 (0.4 ng/mL).
Epidermal keratinocytes isolated from both involved and uninvolved skin of patients with psoriasis were resistant, and 100-fold more 1,25-(OH)2D3 was required to inhibit their DNA synthesis. These results afford new insight into the etiology and therapy of psoriasis.
* This work was supported in part by Grant-in-Aid for Special Project Research, Cancer-Bioscience, from the Ministry of Education, Science and Culture, Japan.
Received August 8, 1988.
This article has been cited by other articles:
![]() |
D. Zehnder, R. Bland, M. C. Williams, R. W. McNinch, A. J. Howie, P. M. Stewart, and M. Hewison Extrarenal Expression of 25-Hydroxyvitamin D3-1{{alpha}}-Hydroxylase J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 888 - 894. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |